is 6% of the US population and one of the stingiest when it comes to Medicaid reimbursements.
On top of that, only the two least significant competitors have been taken out of play - SQNM is still up against Verinata and getting creamed.
Shorts are getting scared. I'll tell you what: only a fool would go short SQNM at these levels.
Sentiment: Strong Buy
We do agree on that.
This is no price to be shorting at.
Not sure you're going to see a comeback any time soon though. It's all kind of digital or binomial from here.
IP rulings are going to be favorable (best case $9) or unfavorable (then $1).
One month to cover though.
Sounds like you are afraid of a comeback. Well, it's going to happen anyway.